Ascend Biopharmaceuticals

Ascend Biopharmaceuticals

Ascend Biopharmaceuticals is a biotechnology company developing immunotherapies for treating metastatic cancers.

Ascend Biopharmaceuticals is a company that is developing treatments for metastatic cancers and the cells that promote and influence tumor micro-environments. The company was founded in South Melbourne, Victoria, Australia.

The company's medicines are designed to treat primary and recurrent forms of metastatic cancers. Ascend Biopharmaceuticals uses viral vectors and affinity agents in order to create their small molecule payloads, which they deliver through immune modulators, kinase inhibitors, or chemotherapeutics.

The cells that Ascend's technologies and treatments are designed to destroy grow in tumor environments, and regulate the growth of tumor cells.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Ascend Biopharmaceuticals Announces Encouraging Phase I/IIa Interim Results of ASN-002 Treatment of Nodular Basal Cell Carcinoma (nBCC)

Ascend Biopharmaceuticals Ltd

Web

Transgene Grants Ascend Biopharmaceuticals a License to TG1042, an Immunotherapy to Treat Basal Cell Carcinoma, a Common Type of Skin Cancer

Business Wire

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.